XLV241227C117000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Enanta to Appeal as Pfizer Wins Paxlovid Patent Ruling
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Pfizer (PFE.US) cancer small molecule combination therapy has received accelerated approval from the FDA.
Pfizer (PFE.US) recently announced that the USA FDA has expedited the approval of the BRAF inhibitor Braftovi (encorafenib) in combination with Erbitux (cetuximab) and the mFOLFOX6 treatment regimen (which includes fluorouracil, leucovorin, and oxaliplatin) for the treatment of patients with metastatic colorectal cancer (mCRC) who have been tested positive for the BRAF V600E mutation.
Futu Daily News | The Federal Reserve FOMC voting committee has a new lineup in the new year! The policy stance is expected to further polarize between dovish and hawkish factions; with the Christmas holiday approaching, Hong Kong stocks open half a day t
The NASDAQ 100 Index has been rebalanced, with the weights of Tesla, Meta, and Broadcom decreasing; competition in wearable devices is intensifying! Meta plans to add a display to its smart glasses; the "Santa Claus rally" is late this year, Analysts say there will still be opportunities after the holidays.
U.S. stocks closed higher | The three major Indexes collectively rose, with the Nasdaq increasing by nearly 1%; chip stocks surged, with Broadcom and Taiwan Semiconductor rising over 5%, and NVIDIA increasing nearly 4%.
① The Nasdaq China Golden Dragon Index rose by 0.91%; ② The PHLX Semiconductor Index rose by over 3%; ③ MicroStrategy purchased 5,262 Bitcoins; ④ The suspect in the UnitedHealth executive's murder case pleaded not guilty.
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.
Eli Lilly Stock Is Rising Monday: What's Going On?
Weekly ETF Flows: Seven Out of 11 Sectors Record Outflows; Bitcoin Continues to Lead With Higher Inflows
14 Analysts Have This To Say About Danaher
Unpacking the Latest Options Trading Trends in UnitedHealth Group
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
2024's 'Biggest Loses' That Could See Reversal in 2025
Thermo Fisher Scientific Analyst Ratings
Sector Update: Health Care Stocks Fall Premarket Monday
ETF Shorts Were up Last Week, Led by Large-cap ETFs
Leading And Lagging Sectors For December 23, 2024
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Investors Assess Fed's Interest Rate Outlook
Health Care Select Sector SPDR ETF Declares Quarterly Distribution of $0.6217